Mountain High Appoints Leading Cannabis Authority Dr. Robert Melamede Ph.D. as Scientific Advisor
April 16 2014 - 4:20AM
Marketwired
Mountain High Appoints Leading Cannabis Authority Dr. Robert
Melamede Ph.D. as Scientific Advisor
DENVER, CO--(Marketwired - Apr 16, 2014) - Mountain High
Acquisitions Corp. (OTCQB: MYHI) ("Mountain High" or the
"Company"), is pleased to announce that leading cannabis authority
Dr. Robert Melamede, Ph.D. has joined the Advisory Board of the
Company.
"Dr. Melamede is a visionary and a pioneer in the field of
medicinal cannabis research, so we are greatly honored that he has
agreed to join our team as Scientific Advisor," stated Mr. Alan
Smith, President of Mountain High Acquisitions Corp. "His
years of leading scientific research and cannabis advocacy have
earned him a reputation as a vital industry source of knowledge,
opinion, industry contacts, and inspiration. As our new
Scientific Advisor, we are confident that he will be instrumental
in helping us achieve our corporate objectives. In particular,
his advice will be invaluable as we provide additional
complementary services to current and future cannabis growing
tenants and strategically develop our properties for use by the
cannabis industry."
Dr. Robert Melamede is recognized as a leading authority on the
therapeutic uses of cannabis, and has authored or co-authored
dozens of papers on a wide variety of scientific subjects. Dr.
Melamede is the President of Cannabis Science, Inc. (OTCQB: CBIS),
a medical cannabis research and development company, and an advisor
to Enertopia Corporation (OTCQB: ENRT), a company with a medical
marijuana cultivation joint venture. Dr. Melamede also serves
on the Editorial Board of The Journal of the International
Association for Cannabis as Medicine, the Scientific Advisory Board
of Americans for Safe Access, Sensible Colorado, Scientific Advisor
for Cannabis Therapeutics, as well as a variety other of state
dispensaries and marijuana patient advocacy groups. Dr.
Melamede has a Ph.D. in Molecular Biology and Biochemistry from the
City University of New York. Dr. Melamede retired as Chairman
of the Biology Department at University of Colorado, Colorado
Springs, in 2005, where he continues to teach and research
cannabinoids, cancer, and DNA repair.
About Mountain High Acquisitions Corp. (MYHI)
Mountain High Acquisitions Corp. is a strategic real estate
holding company whose primary focus is the acquisition and
development of commercial properties to be leased and utilized by
the marijuana industry. Mountain High's current portfolio
includes three Colorado properties zoned for commercial marijuana
cultivation: Isabelle, Madison, and Pueblo.
Disclaimer/Safe Harbor: This Mountain High Acquisitions Corp.
news release contains forward-looking statements within the meaning
of the Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include failure
to meet schedule or performance requirements of the Company's
contracts, the Company's liquidity position, the Company's ability
to obtain new contracts, the emergence of competitors with greater
financial resources and the impact of competitive pricing. In the
light of these uncertainties, the forward-looking events referred
to in this release might not occur as planned or at all. The
Company does not and will not grow, harvest, distribute, or sell
cannabis or any substances that violate United States law or the
Controlled Substances Act, nor does it intend to do so in the
future.
Investor/Media Contact: Mountain High Acquisitions Corp.
Investor Relations (844) 686-0420
(Toll-free) E-mail: Email Contact Website:
www.mountainhighac.com